Athira Pharma, Inc.
Developing small-molecule therapies to slow neurodegeneration in diseases like Alzheimer's.
ATHA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US04746L1044
- LEI:
- Country:
- United States of America
- Address:
- 18706 NORTH CREEK PARKWAY, SUITE 104, 98011 BOTHELL
- Website:
- https://www.athira.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small-molecule therapies to restore neuronal health and slow neurodegeneration. The company's proprietary platform creates novel compounds designed to modulate the HGF (Hepatocyte Growth Factor) signaling system, a naturally occurring repair mechanism, to promote neuro-regeneration and provide neuroprotection. Athira's pipeline is aimed at treating a range of neurodegenerative diseases, including Alzheimer's and Parkinson's disease dementia. The company advances its product candidates through clinical trials to evaluate their safety and efficacy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Athira Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Athira Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Athira Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
